Skip to main content

Amedisys Inc

Exchange: NASDAQSector: HealthcareIndustry: Medical Care Facilities

Amedisys, Inc. is a leading healthcare at home company delivering personalized home health, hospice and high-acuity care services. Amedisys is focused on delivering the care that is best for our patients, whether that is inpatient hospital, palliative, and skilled nursing facility (“SNF”) care in their homes; home-based recovery and rehabilitation after an operation or injury; care focused on empowering them to manage a chronic disease; or hospice care at the end of life. Nearly 3,000 hospitals and more than 110,000 physicians nationwide have chosen Amedisys as a partner in post-acute care. Founded in 1982, headquartered in Baton Rouge, LA with an executive office in Nashville, TN, Amedisys is a publicly held company. With approximately 19,000 employees in 521 care centers in 37 states and the District of Columbia, Amedisys is dedicated to delivering the highest quality of care to the doorsteps of nearly 470,000 patients in need every year, performing more than 10.6 million visits annually.

Did you know?

Net income compounded at -15.6% annually over 6 years.

Current Price

$100.99

+0.01%

GoodMoat Value

$205.64

103.6% undervalued
Profile
Valuation (TTM)
Market Cap$3.31B
P/E38.71
EV
P/B2.92
Shares Out32.82M
P/Sales1.38
Revenue$2.40B
EV/EBITDA14.14

Amedisys Inc (AMED) Insider Trades

AMED Insider Trading Activity

Track insider trading transactions for Amedisys Inc (AMED). Monitor recent buys, sells, and option exercises by officers, directors, and 10% beneficial owners. Insider trading activity can signal management confidence or concern about a stock's future prospects.

Current stock price: $100.99. Market cap: $3.31B. This page displays the most recent insider transactions for AMED, including the insider's name, title, transaction type (purchase, sale, or option exercise), number of shares, and total value. Filter transactions by type to focus on open-market purchases or sales.

Insider buying is often viewed as a bullish signal, as insiders are putting their own capital at risk. Conversely, large insider sales may warrant further investigation. Use GoodMoat's insider trading data alongside financial analysis, quality scores, and valuation tools for a comprehensive view of Amedisys Inc's investment outlook.